![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The impact of direct-acting antiviral treatment for HCV on
hepatocellular carcinoma risk in a large population-based cohort study
|
|
|
AASLD 2022 Nov 4-8
Janjua NZ1,2, Wong S, 1 Jeong D1,2, Makuza JD 1,2, Garcia HV1, Binka M1, Adu P1, Yu A1, Yoshida EM,4 Ramji A,4 Bartlett S1,3, Darvishian M1, 5, Alvarez M1, Krajden M1,3, The BC-HTC Team*
1 BC Centre for Disease Control, Vancouver, BC; 2 School of Population and Public Health; 3 Dept. of Pathology and Laboratory Medicine, 4 Division of Gastroenterology University of British Columbia, 5 BC Cancer, Vancouver, BC, Canada
![1117221](../images/111722/111722-3/1117221.gif)
![1117222](../images/111722/111722-3/1117222.gif)
![1117223](../images/111722/111722-3/1117223.gif)
![1117224](../images/111722/111722-3/1117224.gif)
![1117225](../images/111722/111722-3/1117225.gif)
![1117226](../images/111722/111722-3/1117226.gif)
http://bchtc.med.ubc.ca/
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|